Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
12.8M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
9.45K
-
Shares change
-
-6.95K
-
Total reported value, excl. options
-
$26.2K
-
Value change
-
-$85K
-
Number of buys
-
4
-
Number of sells
-
-2
-
Price
-
$2.77
Significant Holders of Biofrontera Inc. - Common Stock, par value $0.001 per share (BFRI) as of Q4 2023
9 filings reported holding BFRI - Biofrontera Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
Biofrontera Inc. - Common Stock, par value $0.001 per share (BFRI) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.45K shares
of 12.8M outstanding shares and own 0.07% of the company stock.
Largest 9 shareholders include BlackRock Inc. (4.62K shares), Tower Research Capital LLC (TRC) (3.17K shares), JPMORGAN CHASE & CO (825 shares), OSAIC HOLDINGS, INC. (609 shares), MORGAN STANLEY (200 shares), BANK OF AMERICA CORP /DE/ (11 shares), WELLS FARGO & COMPANY/MN (7 shares), UBS Group AG (0 shares), and VANGUARD GROUP INC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.